Heike E. Daldrup-Link

Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow.

Comparison between gadopentetate and feruglose (Clariscan)-enhanced MR-mammography: preliminary clinical experience.

Highly efficient paramagnetic labelling of embryonic and neuronal stem cells.

Macromolecular contrast agents for MR mammography: current status.

Targeting of hematopoietic progenitor cells with MR contrast agents.

Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: initial phase II multicenter trial.

Macromolecular contrast medium (feruglose) versus small molecular contrast medium (gadopentetate) enhanced magnetic resonance imaging: differentiation of benign and malignant breast lesions.

Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy.

Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro.

Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation.

In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging.

Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment.

Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX.

Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.

Mixture model approach to tumor classification based on pharmacokinetic measures of tumor permeability.

Ferumoxtran-10-enhanced MR imaging of the bone marrow before and after conditioning therapy in patients with non-Hodgkin lymphomas.

T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning.

Ultrasmall supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: a comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol.

MRI of arthritis: comparison of ultrasmall superparamagnetic iron oxide vs. Gd-DTPA.

光学成像的实验性关节炎使用同种异体白细胞用近红外荧光探针标记。

Imaging of tumor angiogenesis: current approaches and future prospects.

MR imaging of therapy-induced changes of bone marrow.

Cell labeling with the positive MR contrast agent Gadofluorine M.

MR imaging of antigen-induced arthritis with a new, folate receptor-targeted contrast agent.

Imaging characteristics of DHOG, a hepatobiliary contrast agent for preclinical microCT in mice.

Receptor imaging of pediatric tumors: clinical practice and new developments.

Cell tracking with optical imaging.

Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumors.

Detection of postoperative granulation tissue with an ICG-enhanced integrated OI-/X-ray System.

Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study.

Optical imaging of cellular immunotherapy against prostate cancer.

New perspectives on bone marrow contrast agents and molecular imaging.

MR imaging of pediatric arthritis.

The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells.

Accelerated stem cell labeling with ferucarbotran and protamine.

Optical imaging of the peri-tumoral inflammatory response in breast cancer.

An optical imaging method to monitor stem cell migration in a model of immune-mediated arthritis.

Labeling human embryonic stem cell-derived cardiomyocytes with indocyanine green for noninvasive tracking with optical imaging: an FDA-compatible alternative to firefly luciferase.

Labeling human mesenchymal stem cells with fluorescent contrast agents: the biological impact.

Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133.

Indocyanine green-enhanced imaging of antigen-induced arthritis with an integrated optical imaging/radiography system.

Monitoring of natural killer cell immunotherapy using noninvasive imaging modalities.

MR signal characteristics of viable and apoptotic human mesenchymal stem cells in matrix-associated stem cell implants for treatment of osteoarthritis.

A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: A new approaches to neuroblastoma therapy (NANT) study.

A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study.

MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles.

Magnetic Resonance Imaging of Ferumoxide-Labeled Mesenchymal Stem Cells in Cartilage Defects: In Vitro and In Vivo Investigations.

Engineering stem cells for treatment of osteochondral defects.

Differentiation of Normal Thymus from Anterior Mediastinal Lymphoma and Lymphoma Recurrence at Pediatric PET/CT.

Intravenous ferumoxytol allows noninvasive MR imaging monitoring of macrophage migration into stem cell transplants.

High-resolution MR imaging of the orbit in patients with retinoblastoma.

Iron administration before stem cell harvest enables MR imaging tracking after transplantation.

Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.

(18)F-FDG PET/CT scans for children and adolescents - authors' reply.

Basic science research in pediatric radiology - how to empower the leading edge of our field.

Value of 18F-FDG PET and PET/CT for evaluation of pediatric malignancies.

White Paper on P4 Concepts for Pediatric Imaging.

Speeding up PET/MR for cancer staging of children and young adults.

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.

Ferumoxytol Is Not Retained in Kidney Allografts in Patients Undergoing Acute Rejection.

Transfer learning on fused multiparametric MR images for classifying histopathological subtypes of rhabdomyosarcoma.

Bone marrow oedema predicts bone collapse in paediatric and adolescent leukaemia patients with corticosteroid-induced osteonecrosis.

A PET/MR Imaging Approach for the Integrated Assessment of Chemotherapy-induced Brain, Heart, and Bone Injuries in Pediatric Cancer Survivors: A Pilot Study.

Magnetic Resonance Imaging of Tumor-Associated Macrophages: Clinical Translation.

Tracking Cell Transplants in Femoral Osteonecrosis with Magnetic Resonance Imaging: A Proof-of-Concept Study in Patients.

Tracking Stem Cell Implants in Cartilage Defects of Minipigs by Using Ferumoxytol-enhanced MRI.

How to Prevent a Leaky Pipeline in Academic Radiology: Insights From a Faculty Survey.

Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.

Comparison of ferumoxytol- and gadolinium chelate-enhanced MRI for assessment of sarcomas in children and adolescents.

Artificial intelligence enables whole-body positron emission tomography scans with minimal radiation exposure.

Challenges and Initiatives in Diversity, Equity and Inclusion in Cancer Molecular Imaging.

Increasing Diversity in Radiology and Molecular Imaging: Current Challenges.

Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.

A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas.

Ferumoxytol magnetic resonance imaging detects joint and pleural infiltration of bone sarcomas in pediatric and young adult patients.

PET/MRI Improves Management of Children with Cancer.

In Vivo Evaluation of Near-Infrared Fluorescent Probe for TIM3 Targeting in Mouse Glioma.

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.

Diagnostic Accuracy of 2-[F]FDG-PET and whole-body DW-MRI for the detection of bone marrow metastases in children and young adults.

In vivo imaging of nanoparticle-labeled CAR T cells.

Detection of bone marrow metastases in children and young adults with solid cancers with diffusion-weighted MRI.

Low-count whole-body PET/MRI restoration: an evaluation of dose reduction spectrum and five state-of-the-art artificial intelligence models.

Improved Detection of Bone Metastases in Children and Young Adults with Ferumoxytol-enhanced MRI.

An Online Repository for Pre-Clinical Imaging Protocols (PIPs).

Rethinking Brain Cancer Therapy: Tumor Enzyme Activatable Theranostic Nanoparticles.

Writing a review article - Are you making these mistakes?

MegaPro, a clinically translatable nanoparticle for tracking of stem cell implants in pig cartilage defects.

Co-Clinical Imaging Metadata Information (CIMI) for Cancer Research to Promote Open Science, Standardization, and Reproducibility in Preclinical Imaging.

AI Transformers for Radiation Dose Reduction in Serial Whole-Body PET Scans.

Comparison of diffusion-weighted MRI and [F]FDG PET/MRI for treatment monitoring in pediatric Hodgkin and non-Hodgkin lymphoma.

Novel Clinically Translatable Iron Oxide Nanoparticle for Monitoring Anti-CD47 Cancer Immunotherapy.

Increased Metabolic Activity of the Thymus and Lymph Nodes in Pediatric Oncology Patients After Coronavirus Disease 2019 Vaccination.

Musculoskeletal imaging of senescence.